Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 351 to 375 of about 5882

Previous 25

Website Changes

03/07/2023

Learnings from Pilot Study: Creating Treatment Templates to Serve More Glioblastoma Patients

03/06/2023

Foundation stirs controversy by charging cancer patients $83,000 for unproven but promising experimental drug

03/06/2023

Musella Foundation Copay Program now open to new and renewal patients!

02/10/2023

A Critical Analysis of Neuro-Oncology Clinical Trials

02/10/2023

Immunotoxin-aCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models

02/08/2023

Dose-dependent efficacy of bevacizumab in recurrent glioblastoma

02/08/2023

Musella Foundation Copay Program now closed to new and renewal patients

02/03/2023

OKN-007 Expanded Access for Pediatric Patients with Diffuse Midline Glioma(including DIPG)

01/15/2023

Targeting the IL4 Receptor with MDNA55 in Patients with Recurrent Glioblastoma: Results of a Phase 2b Trial

01/15/2023

Drug Against Most Common Pediatric Brain Cancer Achieves Trial Success

01/14/2023

Feinstein Institutes, Northwell Use Ultrasound to Treat Brain Tumors in Novel Clinical Trial

01/14/2023

New drug combination may effectively treat often fatal childhood brain tumor

01/06/2023

Webinar on Focused Ultrasound for the treatment of brain tumors. Monday 1/9/23 at 7pm Eastern

01/06/2023

Musella Foundation Brain Tumor Copay Program now open for new and renewal applications!

01/06/2023

Lifespan researchers announce major breakthrough in brain cancer vaccine trial.

12/29/2022

Cracking the mystery behind a deadly brain cancer

12/19/2022

Webinar on Focused Ultrasound for the treatment of brain tumors

12/16/2022

Autonomous rhythmic activity in glioma networks drives brain tumour growth

12/16/2022

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

12/16/2022

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

12/08/2022

Musella Foundation Brain Tumor Treatment Copayment Assistance program is now closed to new and renewal patients

12/06/2022

DcVax Webinar with guest speaker Dr Linda Liau posted on our website!

12/05/2022

CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA

12/05/2022

Our webinar with Dr Linda Liau on DcVax is tonight 12/5/22 at 8:30pm Eastern

12/02/2022

Musella Foundation Brain Tumor Copay Program now open for new and renewal applications!

Our privacy / cookie policy has changed.
Click HERE to read it!